The fund endured a difficult phase in 2018 and 2019 but has picked up since last year. Its history reveals alternating bouts of sharp outperformance and underperformance, but a healthy longer term return profile.
₹399/month
Monthly PLAN
Billed Amount ₹399
No Trial Period
₹208/month
(Save 49%)
Yearly PLAN
Billed Amount ₹2,499
15 Days Trial +Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year PLAN
Billed Amount ₹3,599
15 Days Trial +Includes DocuBay and TimesPrime Membership.
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks